Our findings are consistent with the previous studies that showed that both BCL2 and p53 were expressed in peripheral T-cell lymphomas (PTCL), including CTCL, and constituted an independent prognostic factor that correlated significantly with the progression of the disease [12]. The gene discussed is TP53; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.